InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,025.09
(
0.13%
)
US TECH 100
16,935.20
(
0.44%
)
Dow Jones
37,979.26
(
0.20%
)
Brent Oil
83.23
(
-0.37%
)
Bitcoin
58,646.71
(
0.70%
)
Post# of 2338044
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trons

Send PM Follow Ignore
Followers 39
Posts 3113
Boards Moderated 0
Alias Born 01/04/2008

Trons

Re: None

Tuesday, 05/16/2023 10:39:41 AM

Tuesday, May 16, 2023 10:39:41 AM

Post# of 2338044
$INAB $2.62 headed to $20 on major cancer developments! Its lead product candidates include INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up